Docstoc

Pediatric Diabetes Registry – A Milestone for Diabetes Research (DOC)

Document Sample
Pediatric Diabetes Registry – A Milestone for Diabetes Research (DOC) Powered By Docstoc
					Pediatric Diabetes Registry – A Milestone for Diabetes Research

RemedyMD’s solution aims to solve $174 billion problem by shifting focus
towards research based on more comprehensive scientific evidence

SALT LAKE CITY, US – December 05, 2009 -- RemedyMD , the leading provider
of Disease Registry software, today announced the first nationwide
Pediatric Diabetes Registry. The new registry was developed to help
clinicians and researchers identify which interventions are most
appropriate for specific patient populations.

Details about the registry:
http://www.remedymd.com/cer100/pediatric_diabetes.html

RemedyMD’s pediatric diabetes registry tracks patient outcomes over time
including changes in HgA1c, LDL cholesterol and insulin levels.
Researchers and clinicians can also track HgA1c by medication or
medication class and easily generate reports showing results by multiple
demographic or clinical indicators such as:
* Age
* Gender
* Ethnicity
* Insurance type

The new registry contains 1,500+ pediatric diabetes-specific fields for
physicians, nurses, social workers, and dietitians to support all
elements of pediatric diabetes research. Additionally, the registry
includes all of the applications, data infrastructure, and tools that
clinicians and researchers need to gather, synthesize and analyze both
phenotypic and genotypic data simultaneously.

“Our experience has shown when you view and report across all data types
at the same time, you discover patterns and associations that are
indistinguishable using traditional methodologies” said Gary D. Kennedy,
Founder and CEO of RemedyMD.

RemedyMD’s new pediatric diabetes registry includes a comprehensive set
of electronic data collection (EDC) forms that are specific to pediatric
diabetes research, ad hoc reporting capability, and pattern recognition
tools that assist users in identifying the most effective treatment
options.

In support of this initiative RemedyMD is seeking additional partners who
have existing data that addresses the specific needs of pediatric
diabetes researchers. All institutions involved in comparative
effectiveness research that are planning on submitting grant proposals
for AHRQ funding are invited to visit:
http://www.remedymd.com/cer100/pediatric_diabetes.html

RemedyMD Resources:
Resource Kit for Comparative Effectiveness Research:
www.remedymd.com/cer_kit.html
Ways to Leverage Pediatric Diabetes Registry:
http://www.remedymd.com/cer100/pediatric_diabetes.html
Comparative Effectiveness Research: www.remedymd.com/cer_home.html
Disease Registry Software: www.remedymd.com/registries_home.html

About RemedyMD
RemedyMD® is the leading provider of specialized software applications,
tools, and data necessary for comparative effectiveness research with
more than 100 pre-built clinical, disease, and patient registry software
applications. RemedyMD solutions are personalized to the institution, the
clinical specialty, and to the individual provider’s preferences enabling
researchers to identify new patterns, facilitate new discoveries, and
improve medical outcomes. For more information, visit www.RemedyMD.com.

Press Contact:
Lane Peterson
RemedyMD
SALT LAKE CITY, US
801.733.3383
lpeterson@remedymd.com
http://www.RemedyMD.com

RemedyMD, Disease Registry Software, Comparative Effectiveness Research,
Patient Registry Software, Clinical Registry Software, Pediatric
Diabetes, Pediatric Diabetes Research, AHRQ Grants, Institute of Medicine
Priorities,

				
DOCUMENT INFO
Description: RemedyMD’s solution aims to solve $174 billion problem by shifting focus towards research based on more comprehensive scientific evidence